ARCA biopharma Announces First Quarter 2021 Financial Results and Provides Corporate Update
Dr. Bristow Dr. Michael Bristow, President and CEO, ARCA biopharma, Inc. Topline data from Phase 2b clinical trial evaluating rNAPc2…
Pharmaceuticals, Biotechnology and Life Sciences
Dr. Bristow Dr. Michael Bristow, President and CEO, ARCA biopharma, Inc. Topline data from Phase 2b clinical trial evaluating rNAPc2…
FOSTER CITY, Calif., May 11, 2021 (GLOBE NEWSWIRE) — Vaxcyte, Inc. (Nasdaq: PCVX), a next-generation vaccine company seeking to improve…
R&D effort refocused on two therapeutic areas with significant unmet medical needs: ACLF and cholestatic diseasesGENFIT well positioned to leverage…
Virtual R&D Day on May 25 to unveil SYK portfolio development strategy and highlight momentum of CDK9 inhibitor program and…
Management will host a conference call today at 4:30 p.m. (ET) to review financial results and provide a corporate updateWOBURN,…
– Topline efficacy results for ongoing Phase 3 study evaluating SB206 as a treatment for molluscum on track for targeted…
Conference call and webcast today at 4:30pm Eastern/1:30pm PacificMENLO PARK, Calif., May 11, 2021 (GLOBE NEWSWIRE) — Talis Biomedical Corporation…
SANTA MONICA, Calif., May 11, 2021 (GLOBE NEWSWIRE) — Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines…
MELBOURNE, Australia and ISTANBUL, Turkey, May 10, 2021 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today…
/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH…